Gene therapies

Article

Ocular applications of gene therapies are increasing, as is our understanding of the molecular pathogenesis of glaucoma.

Ocular applications of gene therapies are increasing, as is our understanding of the molecular pathogenesis of glaucoma. In the Survey of Ophthalmology (Vol 54, No 4) Xuyanf Lie et al., look at Gene Therapy Targeting Glaucoma: Where Are We? and concludes: "Improvements in gene delivery techniques, refinement of vector construction methods, and development of better animal models combine to bring this potential therapy closer to reality."

Recent Videos
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Vikas Chopra at AAO 2024: Advancements in MIGS are transforming patient care
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Brent Kramer, MD, of Vance Thompson Vision speaks at the 2024 AAO meeting
© 2025 MJH Life Sciences

All rights reserved.